相关实验视频

Updated: May 27, 2025

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

胃固体类型差分腺癌患者中JAK2,STAT3和STAT4表达的临床病理学意义:一项回顾性研究

Shinya Umekita¹, Daisuke Kiyozawa¹, Hitoshi Honma¹

¹Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Maidashi 3-1-1, Higashi-Ku, Fukuoka, 812-8582, Japan.

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

|February 17, 2025

概括

简氏激酶 (JAK) /信号转换器和转录激活器 (STAT) 信号与胃癌有关. 高的pSTAT3和低的STAT4表达表明固体类型差异化腺癌的预后不佳.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
癌症研究癌症研究

背景情况:

在胃固体类型差分腺癌中,Janus kinase (JAK) /信号转换器和转录激活器 (STAT) 信号的作用尚未完全理解.
这项研究调查了JAK2,STAT3和STAT4表达在这种癌症亚型中的临床病理学意义.

研究的目的:

确定JAK2,STAT3和STAT4表达在胃固体类型差分腺癌中的临床病理学意义.
探索这些蛋白质之间的关联,不匹配修复状态和患者预后.

主要方法:

对102名原发性固体类型差异化腺癌患者的回顾性分析.
对化JAK2 (pJAK2),化STAT3 (pSTAT3) 和STAT4表达的免疫组织化学分析.
蛋白质表达与不匹配修复状态,临床病理特征和生存结果的相关性.

主要成果:

与熟练的不匹配修复相比,缺乏不匹配修复与更高的pJAK2和STAT4表达有关.
较高的pSTAT3和较低的STAT4表达显著相关于总生存率的降低.
高的pSTAT3和低的STAT4表达,以及熟练的不匹配修复状态,是不利预后的独立指标.

结论:

增加的pJAK2和STAT4表达在胃固体类型差异化腺癌中更为普遍,缺少不匹配修复.
高的pSTAT3和低的STAT4表达可以作为这种癌症类型的有价值的预后生物标志物.

关键词:

这就是JAK2的意思.在MSI中,它是MSI.在 PDA 和 PDA 之间.在STAT3中,我们可以使用STAT3.在STAT4中,我们使用了STAT4.

更多相关视频

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

相关概念视频

The JAK-STAT Signaling Pathway

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...